top of page
Executive Spotlights

Argenx Raises $1.1B in Global Offering for Immunology Advancements

Amsterdam, Netherlands, July 19, 2023 (Globe Newswire) -- Argenx, a global immunology company, has priced a global offering to anticipating approximately $1.1 billion in total gross proceeds. The company aims to drive advancements in severe autoimmune disease treatments.


Read full article here.

Recent Posts

See All

Comments


Life Science Headlines
bottom of page